home / stock / itci / itci articles

ITCI Articles, Intra-Cellular Therapies Inc.

Stock Information
Company Name: Intra-Cellular Therapies Inc.
Stock Symbol: ITCI
Market: NASDAQ
Website: intracellulartherapies.com
Menu
ITCI ITCI Quote ITCI Short ITCI News ITCI Articles ITCI Message Board
Get ITCI Alerts

News, Short Squeeze, Breakout and More Instantly...
China's Bilibili And Ollie's Bargain Outlet Were Among 10 Mid Cap Stocks With Biggest Gains In The Last Week (June 16-June 22, 2024): Are They In Your Portfolio? | Benzinga

These mid-cap stocks were the best performers in the last week. Are they in your portfolio? Bilibili Inc. (NASDAQ:BILI) shares rose 23.32% followi...
Patterson Companies, Silk Road Medical, Micron, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Tuesday | Benzinga

U.S. stocks were slightly higher, with the Dow Jones index gaining around 0.1% on Tuesday. Shares of Patterson Companies, Inc. (NASDAQ:PDCO) rose s...

Intra-Cellular Therapies' Highlights Successful Data From Second Depression Study | Benzinga

Tuesday, Intra-Cellular Therapies Inc (NASDAQ:ITCI) released topline results from Study 502 evaluating lumateperone 42 mg as an adjunctive therapy ...

Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference | Benzinga

NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development...
Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference | Benzinga

NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development ...

Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast | Benzinga

NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the developme...

Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares | Benzinga

NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) ("Intra-Cellular Therapies"), a biopharmaceutical com...
Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday | Benzinga

With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street...

Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial res...

Intra-Cellular Stock Rallies On Successful Late-Stage Depression Treatment Study | Benzinga

Intra-Cellular Therapies Inc (NASDAQ:ITCI) unveiled on Tuesday topline results from Study 501 evaluating lumateperone 42 mg as an adjunctive thera...
Next 10